Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2002 6
2003 8
2004 14
2005 5
2006 4
2007 9
2008 8
2009 5
2010 6
2011 11
2012 3
2013 5
2014 9
2015 9
2016 13
2017 16
2018 11
2019 18
2020 21
2021 30
2022 10
2023 22
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Free article. Clinical Trial.
Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study.
Iversen L, Conrad C, Eidsmo L, Costanzo A, Narbutt J, Pinter A, Kingo K, Rivera Diaz R, Kolbinger F, Nanna M, Frueh JA, Jagiello P. Iversen L, et al. J Eur Acad Dermatol Venereol. 2023 May;37(5):1004-1016. doi: 10.1111/jdv.18846. Epub 2023 Jan 27. J Eur Acad Dermatol Venereol. 2023. PMID: 36606536 Clinical Trial.
Global change and plant-ecosystem functioning in freshwaters.
Pan Y, García-Girón J, Iversen LL. Pan Y, et al. Among authors: iversen ll. Trends Plant Sci. 2023 Jun;28(6):646-660. doi: 10.1016/j.tplants.2022.12.013. Epub 2023 Jan 9. Trends Plant Sci. 2023. PMID: 36628654 Review.
[Artificial intelligence in diagnosing skin diseases].
Thomsen K, Pihl A, Iversen L, Winther O, Lomholt HB, Thomsen SF. Thomsen K, et al. Among authors: iversen l. Ugeskr Laeger. 2021 Feb 15;183(7):V10200761. Ugeskr Laeger. 2021. PMID: 33660596 Free article. Review. Danish.
Comorbidity in Adult Psoriasis: Considerations for the Clinician.
Daugaard C, Iversen L, Hjuler KF. Daugaard C, et al. Among authors: iversen l. Psoriasis (Auckl). 2022 Jun 10;12:139-150. doi: 10.2147/PTT.S328572. eCollection 2022. Psoriasis (Auckl). 2022. PMID: 35712227 Free PMC article. Review.
Old and New Biological Therapies for Psoriasis.
Rønholt K, Iversen L. Rønholt K, et al. Among authors: iversen l. Int J Mol Sci. 2017 Nov 1;18(11):2297. doi: 10.3390/ijms18112297. Int J Mol Sci. 2017. PMID: 29104241 Free PMC article. Review.
227 results